US Stock MarketDetailed Quotes

RKDA Arcadia Biosciences

Watchlist

3.0600
-0.0064-0.21%

Close May 31 16:00 ET

4.17MMarket Cap-1378P/E (TTM)

Arcadia Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

7.39%-3.21M

-9.42%-15.29M

-75.93%-4.15M

14.42%-2.89M

-42.59%-4.8M

29.05%-3.47M

45.97%-13.98M

64.62%-2.36M

59.23%-3.37M

46.01%-3.37M

Net income from continuing operations

74.18%-2.42M

10.42%-13.99M

34.08%-2.85M

10.78%-2.57M

121.54%818K

-103.56%-9.38M

3.24%-15.61M

54.71%-4.33M

-1.41%-2.88M

29.96%-3.8M

Operating gains losses

-111.55%-591K

-41.26%-6.58M

53.62%-583K

44.26%-1.05M

-741.97%-10.07M

1,660.06%5.12M

76.75%-4.66M

91.23%-1.26M

68.76%-1.88M

-288.94%-1.2M

Depreciation and amortization

-28.17%51K

-40.08%287K

-30.23%60K

-1.11%89K

-52.48%67K

-56.17%71K

-54.16%479K

-58.85%86K

-70.39%90K

-48.91%141K

Other non cash items

-70.98%177K

3,185.20%6.44M

17.98%-602K

4.83%608K

2,608.37%5.82M

351.85%610K

-60.16%196K

30.16%-734K

-32.95%580K

571.88%215K

Change In working capital

-420.00%-598K

-361.33%-2.74M

-120.12%-444K

-203.53%-381K

-176.26%-1.8M

86.81%-115K

135.96%1.05M

405.03%2.21M

112.33%368K

-277.46%-653K

-Change in receivables

-407.50%-246K

-68.92%184K

-105.77%-65K

-79.72%162K

-89.23%7K

105.72%80K

1,580.00%592K

15,985.71%1.13M

361.11%799K

291.18%65K

-Change in inventory

918.92%303K

-316.37%-2.42M

-2,293.62%-1.03M

-202.86%-72K

-485.24%-1.28M

-105.53%-37K

146.92%1.12M

-82.46%47K

103.47%70K

140.64%332K

-Change in prepaid assets

35.47%275K

-98.90%1K

57.46%285K

-131.49%-142K

53.94%-345K

-2.40%203K

62.50%91K

-64.37%181K

-7.20%451K

11.67%-749K

-Change in payables and accrued expense

-263.19%-661K

33.76%-512K

-256.72%-210K

79.82%-137K

148.57%17K

5.70%-182K

-99.23%-773K

110.07%134K

-630.11%-679K

-102.08%-35K

-Change in other current assets

----

-87.50%2K

1,400.00%15K

--0

----

110.13%16K

0.00%1K

--0

95.42%-7K

-Change in other current liabilities

-50.28%-269K

--0

-21.73%562K

29.67%-192K

26.25%-191K

0.56%-179K

500.00%6K

-27.03%718K

72.23%-273K

-8,533.33%-259K

Cash from discontinued investing activities

Operating cash flow

7.39%-3.21M

-9.42%-15.29M

-75.93%-4.15M

14.42%-2.89M

-42.59%-4.8M

29.05%-3.47M

45.97%-13.98M

64.62%-2.36M

59.23%-3.37M

46.01%-3.37M

Investing cash flow

Cash flow from continuing investing activities

-98.73%4K

-406.56%-4.34M

-81.49%52K

-98.53%5K

-9,925.00%-4.72M

-57.83%315K

-91.47%1.42M

501.43%281K

267.16%341K

-99.72%48K

Net PPE purchase and sale

-86.67%4K

-87.03%110K

2,533.33%73K

-91.07%5K

-95.83%2K

-95.98%30K

185.83%848K

95.77%-3K

127.45%56K

121.05%48K

Net business purchase and sale

--0

0.00%569K

--0

--284K

--285K

113.39%569K

--284K

--285K

--0

Net investment purchase and sale

----

---5.02M

---21K

--0

----

--0

----

Cash from discontinued investing activities

Investing cash flow

-98.73%4K

-406.56%-4.34M

-81.49%52K

-98.53%5K

-9,925.00%-4.72M

-57.83%315K

-91.47%1.42M

501.43%281K

267.16%341K

-99.72%48K

Financing cash flow

Cash flow from continuing financing activities

-99.91%5K

21.97%5.51M

-99.84%7K

137,525.00%5.51M

-79.37%4.52M

21,400.00%4.52M

Net common stock issuance

--0

19.94%6M

--0

--6M

-80.12%5M

--0

--5M

--0

Proceeds from stock option exercised by employees

0.00%5K

71.43%12K

--0

133.33%7K

--0

25.00%5K

-88.52%7K

--0

-91.18%3K

--0

Net other financing activities

----

-1.84%-497K

--0

---497K

58.00%-488K

--0

----

Cash from discontinued financing activities

Financing cash flow

-99.91%5K

21.97%5.51M

--0

-99.84%7K

--0

137,525.00%5.51M

-79.37%4.52M

--0

21,400.00%4.52M

--0

Net cash flow

Beginning cash position

-68.43%6.52M

-28.03%20.64M

-53.29%10.61M

-36.50%13.48M

-6.33%23M

-28.03%20.64M

78.80%28.69M

-36.05%22.72M

-51.72%21.23M

-25.26%24.55M

Current changes in cash

-235.98%-3.2M

-75.67%-14.13M

-97.25%-4.09M

-293.47%-2.87M

-186.83%-9.51M

156.94%2.35M

-163.62%-8.04M

69.68%-2.08M

117.57%1.49M

-129.80%-3.32M

End cash Position

-85.58%3.32M

-68.43%6.52M

-53.29%10.61M

-36.50%13.48M

-6.33%23M

-28.03%20.64M

-36.05%22.72M

-51.72%21.23M

Free cash flow

7.01%-3.22M

-8.90%-15.3M

-74.01%-4.15M

14.42%-2.89M

-42.48%-4.8M

29.62%-3.47M

47.72%-14.05M

64.70%-2.38M

60.22%-3.37M

47.83%-3.37M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	7.39%-3.21M	-9.42%-15.29M	-75.93%-4.15M	14.42%-2.89M	-42.59%-4.8M	29.05%-3.47M	45.97%-13.98M	64.62%-2.36M	59.23%-3.37M	46.01%-3.37M
Net income from continuing operations	74.18%-2.42M	10.42%-13.99M	34.08%-2.85M	10.78%-2.57M	121.54%818K	-103.56%-9.38M	3.24%-15.61M	54.71%-4.33M	-1.41%-2.88M	29.96%-3.8M
Operating gains losses	-111.55%-591K	-41.26%-6.58M	53.62%-583K	44.26%-1.05M	-741.97%-10.07M	1,660.06%5.12M	76.75%-4.66M	91.23%-1.26M	68.76%-1.88M	-288.94%-1.2M
Depreciation and amortization	-28.17%51K	-40.08%287K	-30.23%60K	-1.11%89K	-52.48%67K	-56.17%71K	-54.16%479K	-58.85%86K	-70.39%90K	-48.91%141K
Other non cash items	-70.98%177K	3,185.20%6.44M	17.98%-602K	4.83%608K	2,608.37%5.82M	351.85%610K	-60.16%196K	30.16%-734K	-32.95%580K	571.88%215K
Change In working capital	-420.00%-598K	-361.33%-2.74M	-120.12%-444K	-203.53%-381K	-176.26%-1.8M	86.81%-115K	135.96%1.05M	405.03%2.21M	112.33%368K	-277.46%-653K
-Change in receivables	-407.50%-246K	-68.92%184K	-105.77%-65K	-79.72%162K	-89.23%7K	105.72%80K	1,580.00%592K	15,985.71%1.13M	361.11%799K	291.18%65K
-Change in inventory	918.92%303K	-316.37%-2.42M	-2,293.62%-1.03M	-202.86%-72K	-485.24%-1.28M	-105.53%-37K	146.92%1.12M	-82.46%47K	103.47%70K	140.64%332K
-Change in prepaid assets	35.47%275K	-98.90%1K	57.46%285K	-131.49%-142K	53.94%-345K	-2.40%203K	62.50%91K	-64.37%181K	-7.20%451K	11.67%-749K
-Change in payables and accrued expense	-263.19%-661K	33.76%-512K	-256.72%-210K	79.82%-137K	148.57%17K	5.70%-182K	-99.23%-773K	110.07%134K	-630.11%-679K	-102.08%-35K
-Change in other current assets	----	-87.50%2K	1,400.00%15K	--0	----	----	110.13%16K	0.00%1K	--0	95.42%-7K
-Change in other current liabilities	-50.28%-269K	--0	-21.73%562K	29.67%-192K	26.25%-191K	0.56%-179K	500.00%6K	-27.03%718K	72.23%-273K	-8,533.33%-259K
Cash from discontinued investing activities
Operating cash flow	7.39%-3.21M	-9.42%-15.29M	-75.93%-4.15M	14.42%-2.89M	-42.59%-4.8M	29.05%-3.47M	45.97%-13.98M	64.62%-2.36M	59.23%-3.37M	46.01%-3.37M
Investing cash flow
Cash flow from continuing investing activities	-98.73%4K	-406.56%-4.34M	-81.49%52K	-98.53%5K	-9,925.00%-4.72M	-57.83%315K	-91.47%1.42M	501.43%281K	267.16%341K	-99.72%48K
Net PPE purchase and sale	-86.67%4K	-87.03%110K	2,533.33%73K	-91.07%5K	-95.83%2K	-95.98%30K	185.83%848K	95.77%-3K	127.45%56K	121.05%48K
Net business purchase and sale	--0	0.00%569K	--0	--0	--284K	--285K	113.39%569K	--284K	--285K	--0
Net investment purchase and sale	----	---5.02M	---21K	--0	----	----	--0	--0	--0	----
Cash from discontinued investing activities
Investing cash flow	-98.73%4K	-406.56%-4.34M	-81.49%52K	-98.53%5K	-9,925.00%-4.72M	-57.83%315K	-91.47%1.42M	501.43%281K	267.16%341K	-99.72%48K
Financing cash flow
Cash flow from continuing financing activities	-99.91%5K	21.97%5.51M	0	-99.84%7K	0	137,525.00%5.51M	-79.37%4.52M	0	21,400.00%4.52M	0
Net common stock issuance	--0	19.94%6M	--0	--0	--0	--6M	-80.12%5M	--0	--5M	--0
Proceeds from stock option exercised by employees	0.00%5K	71.43%12K	--0	133.33%7K	--0	25.00%5K	-88.52%7K	--0	-91.18%3K	--0
Net other financing activities	----	-1.84%-497K	--0	--0	--0	---497K	58.00%-488K	--0	----	----
Cash from discontinued financing activities
Financing cash flow	-99.91%5K	21.97%5.51M	--0	-99.84%7K	--0	137,525.00%5.51M	-79.37%4.52M	--0	21,400.00%4.52M	--0
Net cash flow
Beginning cash position	-68.43%6.52M	-28.03%20.64M	-53.29%10.61M	-36.50%13.48M	-6.33%23M	-28.03%20.64M	78.80%28.69M	-36.05%22.72M	-51.72%21.23M	-25.26%24.55M
Current changes in cash	-235.98%-3.2M	-75.67%-14.13M	-97.25%-4.09M	-293.47%-2.87M	-186.83%-9.51M	156.94%2.35M	-163.62%-8.04M	69.68%-2.08M	117.57%1.49M	-129.80%-3.32M
End cash Position	-85.58%3.32M	-68.43%6.52M	-68.43%6.52M	-53.29%10.61M	-36.50%13.48M	-6.33%23M	-28.03%20.64M	-28.03%20.64M	-36.05%22.72M	-51.72%21.23M
Free cash flow	7.01%-3.22M	-8.90%-15.3M	-74.01%-4.15M	14.42%-2.89M	-42.48%-4.8M	29.62%-3.47M	47.72%-14.05M	64.70%-2.38M	60.22%-3.37M	47.83%-3.37M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall